loadpatents
Patent applications and USPTO patent grants for Shen; Dong-Ming.The latest application filed is for "nlrp modulators".
Patent | Date |
---|---|
Compounds and compositions for treating conditions associated with NLRP activity Grant 11,447,460 - Glick , et al. September 20, 2 | 2022-09-20 |
Nlrp Modulators App 20220267276 - FRANCHI; Luigi ;   et al. | 2022-08-25 |
Compounds And Compositions For Treating Conditions Associated With Nlrp Activity App 20220227707 - KATZ; Jason ;   et al. | 2022-07-21 |
Compounds and compositions for treating conditions associated with NLRP activity Grant 11,370,763 - Franchi , et al. June 28, 2 | 2022-06-28 |
Nlrp Modulators App 20210395241 - GLICK; Gary ;   et al. | 2021-12-23 |
Compounds and compositions for treating conditions associated with NLRP activity Grant 11,203,579 - Franchi , et al. December 21, 2 | 2021-12-21 |
Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 Grant 11,104,690 - Shen , et al. August 31, 2 | 2021-08-31 |
Compounds And Compositions For Treating Conditions Associated With Nlrp Activity App 20210230129 - FRANCHI; Luigi ;   et al. | 2021-07-29 |
Compounds And Compositions For Treating Conditions Associated With Nlrp Activity App 20210171477 - FRANCHI; Luigi ;   et al. | 2021-06-10 |
Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 Grant 10,947,222 - Shen , et al. March 16, 2 | 2021-03-16 |
Compounds and compositions for treating conditions associated with NLRP activity Grant 10,654,816 - Franchi , et al. | 2020-05-19 |
Compounds And Compositions For Treating Conditions Associated With Nlrp Activity App 20200087270 - FRANCHI; Luigi ;   et al. | 2020-03-19 |
Indazole Derivatives Useful As Inhibitors Of Diacylglyceride O-acyltransferase 2 App 20190330239 - Shen; Dong-Ming ;   et al. | 2019-10-31 |
Indole Derivatives Useful As Inhibitors Of Diacylglyceride O-acyltransferase 2 App 20190276443 - Shen; Dong-Ming ;   et al. | 2019-09-12 |
Triazolyl pyrimidinone compounds as PDE2 inhibitors Grant 10,358,435 - Shen , et al. | 2019-07-23 |
Pyrimidinone amide compounds as PDE2 inhibitors Grant 10,285,989 - Shen , et al. | 2019-05-14 |
Pyrazolyl pyrimidinone compounds as PDE2 inhibitors Grant 10,287,269 - Shen , et al. | 2019-05-14 |
Compounds And Compositions For Treating Conditions Associated With Nlrp Activity App 20190119241 - Glick; Gary ;   et al. | 2019-04-25 |
Factor XIA inhibitors Grant 10,214,512 - Xu , et al. Feb | 2019-02-26 |
Heteroaryl-pyrimidinone compounds as PDE2 inhibitors Grant 10,195,201 - Shen , et al. Fe | 2019-02-05 |
Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors Grant 10,174,037 - Shen , et al. J | 2019-01-08 |
6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors Grant 10,160,762 - Shen , et al. Dec | 2018-12-25 |
Factor XIa inhibitors Grant 10,143,681 - Shen , et al. De | 2018-12-04 |
Factor Xia Inhibitors App 20180339977 - Xu; Jiayi ;   et al. | 2018-11-29 |
Heteroaryl-Pyrimidinone Compounds as PDE2 Inhibitors App 20180280390 - Shen; Dong-Ming ;   et al. | 2018-10-04 |
Pyrimidinone Amide Compounds As Pde2 Inhibitors App 20180256575 - Shen; Dong-Ming ;   et al. | 2018-09-13 |
Triazolyl Pyrimidinone Compounds As Pde2 Inhibitors App 20180237422 - Shen; Dong-Ming ;   et al. | 2018-08-23 |
Dihydropyrazolopyrimidinone Compounds As Pde2 Inhibitors App 20180148453 - Shen; Dong-Ming ;   et al. | 2018-05-31 |
6-alkyl Dihydropyrazolopyrimidinone Compounds As Pde2 Inhibitors App 20180134712 - Shen; Dong-Ming ;   et al. | 2018-05-17 |
Pyrazolyl Pyrimidinone Compounds As Pde2 Inhibitors App 20180057480 - Shen; Dong-Ming ;   et al. | 2018-03-01 |
FACTOR XIa INHIBITORS App 20180050022 - Shen; Dong-Ming ;   et al. | 2018-02-22 |
Piperazine derivatives as HIV protease inhibitors Grant 9,840,478 - Williams , et al. December 12, 2 | 2017-12-12 |
Pyrimidone carboxamide compounds as PDE2 inhibitors Grant 9,815,796 - Shen , et al. November 14, 2 | 2017-11-14 |
Pyrimidone Carboxamide Compounds As Pde2 Inhibitors App 20170015633 - Shen; Dong Ming ;   et al. | 2017-01-19 |
Mineralocorticoid receptor antagonists Grant 9,511,052 - Cernak , et al. December 6, 2 | 2016-12-06 |
Mineralocorticoid receptor antagonists Grant 9,403,807 - Crespo , et al. August 2, 2 | 2016-08-02 |
Prolylcarboxypeptidase inhibitors Grant 9,365,539 - Hale , et al. June 14, 2 | 2016-06-14 |
Piperazine Derivatives As Hiv Protease Inhibitors App 20160159752 - Williams; Peter D. ;   et al. | 2016-06-09 |
Mineralocorticoid Receptor Antagonists App 20150284376 - Crespo; Alejandro ;   et al. | 2015-10-08 |
Mineralocorticoid Receptor Antagonists App 20150182503 - Cernak; Timothy A. ;   et al. | 2015-07-02 |
Prolylcarboxypeptidase inhibitors Grant 9,006,268 - Debenham , et al. April 14, 2 | 2015-04-14 |
Mineralocorticoid receptor antagonists Grant 8,933,113 - Crespo , et al. January 13, 2 | 2015-01-13 |
Prolylcarboxypeptidase inhibitors Grant 8,921,394 - Graham , et al. December 30, 2 | 2014-12-30 |
Spiropiperidine prolylcarboxypeptidase inhibitors Grant 8,785,634 - Ding , et al. July 22, 2 | 2014-07-22 |
Prolylcarboxypeptidase inhibitors Grant 8,669,252 - Shen , et al. March 11, 2 | 2014-03-11 |
Mineralocorticoid Receptor Antagonists App 20130331419 - Crespo; Alejandro ;   et al. | 2013-12-12 |
Pyrrolidine derived beta 3 adrenergic receptor agonists Grant 8,604,038 - Edmondson , et al. December 10, 2 | 2013-12-10 |
Prolylcarboxypeptidase inhibitors Grant 8,569,299 - Graham , et al. October 29, 2 | 2013-10-29 |
Novel Prolylcarboxypeptidase Inhibitors App 20130217660 - Shen; Dong-Ming ;   et al. | 2013-08-22 |
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists Grant 8,501,786 - Berger , et al. August 6, 2 | 2013-08-06 |
Novel Prolylcarboxypeptidase Inhibitors App 20130143859 - Graham; Thomas H. ;   et al. | 2013-06-06 |
Novel Prolylcarboxypeptidase Inhibitors App 20130090324 - Debenham; John S. ;   et al. | 2013-04-11 |
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists Grant 8,399,480 - Berger , et al. March 19, 2 | 2013-03-19 |
Novel Prolylcarboxypeptidase Inhibitors App 20130059830 - Ding; Fa-Xiang ;   et al. | 2013-03-07 |
Novel Prolylcarboxypeptidase Inhibitors App 20130040929 - Hale; Jeffrey J. ;   et al. | 2013-02-14 |
Novel Prolylcarboxypeptidase Inhibitors App 20130030019 - Graham; Thomas H. ;   et al. | 2013-01-31 |
Novel Spiropiperidine Prolylcarboxypeptidase Inhibitors App 20130023515 - Ding; Fa-Xiang ;   et al. | 2013-01-24 |
Pyrrolidine derived beta 3 adrenergic receptor agonists Grant 8,354,403 - Edmondson , et al. January 15, 2 | 2013-01-15 |
Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists App 20120258963 - Berger; Richard ;   et al. | 2012-10-11 |
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20120225886 - Edmondson; Scott D. ;   et al. | 2012-09-06 |
Hydroxymethyl pyrrolidines as .beta.3 adrenergic receptor agonists Grant 8,247,415 - Berger , et al. August 21, 2 | 2012-08-21 |
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20120157432 - Edmondson; Scott D. ;   et al. | 2012-06-21 |
Cicletanine derivatives Grant 8,119,806 - Ali , et al. February 21, 2 | 2012-02-21 |
Direct backlight module supporting apparatus and direct backlight module Grant 8,100,548 - Shen January 24, 2 | 2012-01-24 |
Protruding Positioning Pedestal App 20110248136 - SHEN; Dong-Ming | 2011-10-13 |
Substituted pyrazoles, compositions containing such compounds and methods of use Grant 7,989,475 - Parmee , et al. August 2, 2 | 2011-08-02 |
Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists App 20110028461 - Berger; Richard ;   et al. | 2011-02-03 |
Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists App 20110028481 - Berger; Richard ;   et al. | 2011-02-03 |
Direct backlight module supporting apparatus and direct backlight module App 20100073906 - SHEN; Dong-Ming | 2010-03-25 |
Diuretics App 20100029678 - ALI; Amjad ;   et al. | 2010-02-04 |
Ophthalmic Compositions for Treating Ocular Hypertension App 20090281154 - Doherty; James B. ;   et al. | 2009-11-12 |
Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists App 20090253705 - Berger; Richard ;   et al. | 2009-10-08 |
Substituted Pyrazoles, Compositions Containing Such Compounds And Methods Of Use App 20090215825 - Parmee; Emma ;   et al. | 2009-08-27 |
Ophthalmic compositions for treating ocular hypertension Grant 7,576,122 - Shen , et al. August 18, 2 | 2009-08-18 |
Substituted pyrazoles, compositions containing such compounds and methods of use Grant 7,572,922 - Parmee , et al. August 11, 2 | 2009-08-11 |
Ophthalmic compositions for treating ocular hypertension Grant 7,563,816 - Doherty , et al. July 21, 2 | 2009-07-21 |
Ophthalmic compositions for treating ocular hypertension Grant 7,528,163 - Doherty , et al. May 5, 2 | 2009-05-05 |
Ophthalmic Compositions for Treating Ocular Hypertension App 20090062280 - Doherty; James B. ;   et al. | 2009-03-05 |
Ophthalmic compositions for treating ocular hypertension App 20080287489 - Shen; Dong-Ming ;   et al. | 2008-11-20 |
Substituted Pyrazoles as Modulators of Chemokine Receptors App 20080167322 - Pinkerton; Anthony B. ;   et al. | 2008-07-10 |
Ophthalmic Compositions for Treating Ocular Hypertension App 20080097108 - Gao; Ying-Duo ;   et al. | 2008-04-24 |
Ophthalmic Compositions For Treating Ocular Hypertension App 20080032951 - Doherty; James B. ;   et al. | 2008-02-07 |
Ophthalmic Compositions for Treating Ocular Hypertension App 20070293558 - Gao; Ying-Duo ;   et al. | 2007-12-20 |
Ophthalmic compositions for treating ocular hypertension App 20060276504 - Shen; Dong-Ming ;   et al. | 2006-12-07 |
Pyrrolidine modulators of CCR5 chemokine receptor activity Grant 7,125,887 - Hale , et al. October 24, 2 | 2006-10-24 |
Opthalmic compositions for treating ocular hypertension App 20060148805 - Chen; Meng Hsin ;   et al. | 2006-07-06 |
Spirocyclic ureas, compositions containing such compounds and methods of use App 20060116366 - Parmee; Emma R. ;   et al. | 2006-06-01 |
Substituted pyrazoles, compositions containing such compounds and methods of use App 20060084681 - Parmee; Emma ;   et al. | 2006-04-20 |
Ophthalmic compositions for treating ocular hypertension App 20060020000 - Doherty; James B. ;   et al. | 2006-01-26 |
Ophthalmic compositions for treating ocular hypertension App 20050256117 - Chen, Meng Hsin ;   et al. | 2005-11-17 |
Pyrrolidine modulators of ccr5 chemokine receptor activity App 20040087552 - Hale, Jeffrey J ;   et al. | 2004-05-06 |
Pyrrolidine modulators of CCR5 chemokine receptor activity App 20020198178 - Willoughby, Christopher A. ;   et al. | 2002-12-26 |
N-cyclopentyl modulators of chemokine receptor activity App 20020120146 - Finke, Paul E. ;   et al. | 2002-08-29 |
Pyrrolidine modulators of CCR5 chemokine receptor activity App 20020094989 - Hale, Jeffrey J. ;   et al. | 2002-07-18 |
N-cyclopentyl modulators of chemokine receptor activity Grant 6,358,979 - Finke , et al. March 19, 2 | 2002-03-19 |
Deposit control additives and fuel compositions containing the same Grant 5,334,228 - Ashjian , et al. August 2, 1 | 1994-08-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.